1,000
Participants
Start Date
November 30, 2020
Primary Completion Date
March 31, 2024
Study Completion Date
June 30, 2024
Standard of care genetic testing group
N/A - no intervention as this is an observational study.
ACTIVE_NOT_RECRUITING
Columbia University Irving Medical Center, New York
ACTIVE_NOT_RECRUITING
DNA Microarray CGH Laboratory, Department of Pathology, University of Rochester Medical Center, West Henrietta
RECRUITING
Greenwood Genetic Center, Greenwood
ACTIVE_NOT_RECRUITING
Praxis Genomics, Atlanta
ACTIVE_NOT_RECRUITING
Augusta University Research Institute, Augusta
ACTIVE_NOT_RECRUITING
University of Iowa Hospitals & Clinics, Molecular Pathology, Iowa City
ACTIVE_NOT_RECRUITING
Medical College of Wisconsin, Milwaukee
RECRUITING
Lineagen (A Bionano Genomics Company), Salt Lake City
Lead Sponsor
Collaborators (1)
University of Rochester
OTHER
Columbia University
OTHER
Greenwood Genetic Center
OTHER
Praxis Genomics
UNKNOWN
Augusta University
OTHER
Medical College of Wisconsin
OTHER
University of Iowa
OTHER
Bionano Genomics
INDUSTRY